{"id":"https://openalex.org/W7223133162","doi":"https://doi.org/10.3389/fonc.2026.2001564","title":"The consolidation paradox: rethinking thoracic radiotherapy in extensive-stage small cell lung cancer in the immunotherapy era","display_name":"The consolidation paradox: rethinking thoracic radiotherapy in extensive-stage small cell lung cancer in the immunotherapy era","publication_year":2026,"publication_date":"2026-10-21","ids":{"openalex":"https://openalex.org/W7223133162","doi":"https://doi.org/10.3389/fonc.2026.2001564","pmid":"https://pubmed.ncbi.nlm.nih.gov/42985426","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13732451"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2026.2001564","doi":"https://doi.org/10.3389/fonc.2026.2001564","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2001564","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2001564/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2001564/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013108855","display_name":"Patrizia Ciammella","orcid":"https://orcid.org/0000-0003-4315-1645","observed_orcids":["https://orcid.org/0000-0003-4315-1645"]},"institutions":[{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Patrizia Ciammella","raw_affiliation_strings":["Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia","institution_ids":["https://openalex.org/I4210090508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061146094","display_name":"Emanuele Al\u00ec","orcid":"https://orcid.org/0000-0002-6196-5864","observed_orcids":["https://orcid.org/0000-0002-6196-5864"]},"institutions":[{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Emanuele Al\u00ec","raw_affiliation_strings":["Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia","institution_ids":["https://openalex.org/I4210090508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063794095","display_name":"Federico Iori","orcid":"https://orcid.org/0000-0002-9482-1832","observed_orcids":["https://orcid.org/0000-0002-9482-1832"]},"institutions":[{"id":"https://openalex.org/I4210090508","display_name":"Azienda Sanitaria Unit\u00e0 Locale di Reggio Emilia","ror":"https://ror.org/001bbwj30","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210090508"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federico Iori","raw_affiliation_strings":["Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Radiation Oncology Unit, Azienda USL-IRCCS di Reggio Emilia","institution_ids":["https://openalex.org/I4210090508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013108855"],"corresponding_institution_ids":["https://openalex.org/I4210090508"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.57803022,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"2001564","last_page":"2001564"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9818999767303467,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.9860000014305115},{"id":"https://openalex.org/keywords/thoracic-radiotherapy","display_name":"thoracic radiotherapy","score":0.8650000095367432},{"id":"https://openalex.org/keywords/consolidation-radiotherapy","display_name":"consolidation radiotherapy","score":0.8740000128746033},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.8659999966621399},{"id":"https://openalex.org/keywords/radiotherapy-toxicity","display_name":"radiotherapy toxicity","score":0.4560000002384186},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.7549999952316284},{"id":"https://openalex.org/keywords/competing-risks","display_name":"competing risks","score":0.31700000166893005},{"id":"https://openalex.org/keywords/radiographic-progression","display_name":"radiographic progression","score":0.6129999756813049},{"id":"https://openalex.org/keywords/pulmonary-reserve","display_name":"pulmonary reserve","score":0.5130000114440918},{"id":"https://openalex.org/keywords/crest-trial","display_name":"CREST trial","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8547000288963318},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.7102000117301941},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6080999970436096},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5856999754905701},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5630999803543091},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5246000289916992},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4821000099182129},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.45910000801086426},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.38530001044273376},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34929999709129333},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.33880001306533813},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.31529998779296875},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3125},{"id":"https://openalex.org/C187625094","wikidata":"https://www.wikidata.org/wiki/Q7388452","display_name":"SABR volatility model","level":4,"score":0.31029999256134033},{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.3012999892234802},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.29249998927116394},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.29089999198913574},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.2806999981403351},{"id":"https://openalex.org/C2779562246","wikidata":"https://www.wikidata.org/wiki/Q16918881","display_name":"Prophylactic cranial irradiation","level":4,"score":0.2782999873161316},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.27379998564720154},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.25609999895095825}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2026.2001564","doi":"https://doi.org/10.3389/fonc.2026.2001564","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2001564","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2001564/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmid:42985426","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985426","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13732451","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13732451/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:4d48132922c145338935ac0c42ca259a","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/4d48132922c145338935ac0c42ca259a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 16 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2026.2001564","doi":"https://doi.org/10.3389/fonc.2026.2001564","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2026.2001564","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.2001564/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3584898954","display_name":null,"funder_award_id":"2023YFF1305104","funder_id":"https://openalex.org/F4320335777","funder_display_name":"National Key Research and Development Program of China"}],"funders":[{"id":"https://openalex.org/F4320335777","display_name":"National Key Research and Development Program of China","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223133162.pdf","grobid_xml":"https://content.openalex.org/works/W7223133162.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W2038981426","https://openalex.org/W2098683814","https://openalex.org/W2113966750","https://openalex.org/W2140469315","https://openalex.org/W2154323253","https://openalex.org/W2189143821","https://openalex.org/W2264767503","https://openalex.org/W2323020638","https://openalex.org/W2599941031","https://openalex.org/W2610123800","https://openalex.org/W2642802273","https://openalex.org/W2750913206","https://openalex.org/W2753065806","https://openalex.org/W2793974615","https://openalex.org/W2893960509","https://openalex.org/W2900347882","https://openalex.org/W2901690408","https://openalex.org/W2947220371","https://openalex.org/W2965190971","https://openalex.org/W2977392388","https://openalex.org/W2978349873","https://openalex.org/W3121328438","https://openalex.org/W4401820390","https://openalex.org/W4402519167","https://openalex.org/W4412077970","https://openalex.org/W7117544563","https://openalex.org/W7163406305","https://openalex.org/W7167796345","https://openalex.org/W7167808946","https://openalex.org/W7202180590"],"related_works":["https://openalex.org/W4412886359","https://openalex.org/W4407631400","https://openalex.org/W4385850390","https://openalex.org/W4402908903","https://openalex.org/W4409361810","https://openalex.org/W4386137644","https://openalex.org/W7156748010","https://openalex.org/W4316590927","https://openalex.org/W4368362394","https://openalex.org/W4309848487"],"abstract_inverted_index":{"The":[0,308],"role":[1,65],"of":[2,142,216,225,236,246,275,295,317],"thoracic":[3,46,297,306,332],"radiotherapy":[4,47,81,106],"in":[5,14,174,197,258],"extensive-stage":[6],"small":[7],"cell":[8],"lung":[9],"cancer":[10],"(ES-SCLC)":[11],"remains":[12],"uncertain":[13],"the":[15,19,22,54,69,98,125,280,285,293,302,315],"chemo-immunotherapy":[16,58,109],"era.":[17],"In":[18,97,124],"pre-immunotherapy":[20],"era,":[21],"phase":[23,100,127,183],"3":[24,101],"CREST":[25],"trial":[26,312],"did":[27,110,189],"not":[28,51,111,190,243,254],"meet":[29],"its":[30,63],"primary":[31],"overall-survival":[32],"endpoint":[33],"but":[34,195],"showed":[35,218],"reduced":[36,247],"progression":[37,228,333,337,341],"and":[38,71,91,114,121,144,187,202,241,263,335,338],"higher":[39,140,234],"2-year":[40],"overall":[41,226],"survival":[42,113],"rates":[43,141],"with":[44,117,138,149,155,170,229,231],"consolidative":[45],"(cTRT).":[48],"cTRT":[49,132,257],"was":[50,115,136,168],"incorporated":[52],"into":[53],"pivotal":[55],"trials":[56,321],"establishing":[57],"as":[59,342],"first-line":[60],"treatment,":[61],"leaving":[62],"contemporary":[64,72],"undefined.":[66],"We":[67,278],"reviewed":[68],"historical":[70],"evidence,":[73],"grouping":[74],"prospective":[75],"studies":[76,179],"by":[77,328],"strategy:":[78],"early":[79,104],"concurrent":[80,105],"during":[82,86,107,133],"induction,":[83],"post-induction":[84,318],"consolidation":[85],"maintenance,":[87],"low-dose":[88],"immunomodulatory":[89],"radiotherapy,":[90,156,230],"thoracic-only":[92],"versus":[93],"combined":[94],"thoracic/extrathoracic":[95],"irradiation.":[96,307],"randomized":[99,126,310],"TRIPLEX":[102],"trial,":[103,130],"induction":[108],"improve":[112],"associated":[116,137,154,169],"more":[118],"adverse":[119,146,172],"events":[120,173],"non-progression":[122],"deaths.":[123],"2":[128,184],"TREASURE":[129,217],"conventional-dose":[131],"atezolizumab":[134],"maintenance":[135],"substantially":[139],"serious":[143,276],"fatal":[145,171],"events,":[147],"together":[148],"marked":[150],"lymphocyte":[151],"depletion":[152],"temporally":[153],"although":[157],"all":[158],"patients":[159,260,272],"had":[160],"ECOG":[161],"performance":[162],"status":[163],"0-1;":[164],"lower":[165],"baseline":[166],"DLCO":[167],"an":[175],"exploratory":[176],"analysis.":[177],"Single-arm":[178],"(SAKK":[180],"15/19,":[181],"a":[182,192,219,232],"adebrelimab":[185],"study,":[186],"MATCH)":[188],"report":[191,331],"comparable":[193],"signal,":[194],"differences":[196],"design,":[198],"dose,":[199],"systemic":[200,289],"agent,":[201],"adverse-event":[203],"ascertainment":[204],"preclude":[205],"attributing":[206],"this":[207],"contrast":[208],"to":[209,270],"any":[210],"single":[211],"factor.":[212],"A":[213],"competing-risks":[214],"analysis":[215],"numerically":[220,233],"lower,":[221],"non-significant":[222],"cumulative":[223],"incidence":[224,235],"radiologic":[227],"death":[237,339],"without":[238,340],"documented":[239],"progression,":[240],"does":[242,253],"constitute":[244],"evidence":[245,251],"intrathoracic":[248],"progression.":[249],"Current":[250],"therefore":[252],"support":[255],"routine":[256],"ES-SCLC":[259],"receiving":[261],"chemo-immunotherapy,":[262],"conventional":[264],"eligibility":[265],"criteria":[266],"may":[267,291],"be":[268],"insufficient":[269],"identify":[271],"at":[273],"risk":[274],"toxicity.":[277],"propose":[279],"term":[281],"\"Consolidation":[282],"Paradox\"":[283],"for":[284,305],"hypothesis":[286],"that":[287],"improved":[288],"control":[290,299],"increase":[292],"value":[294],"residual":[296],"disease":[298],"while":[300],"narrowing":[301],"safety":[303],"margin":[304],"ongoing":[309],"RAPTOR/NRG-LU007":[311],"will":[313],"address":[314],"efficacy":[316],"consolidation;":[319],"future":[320],"should":[322],"also":[323],"record":[324],"immune-cell":[325],"dosimetry,":[326],"stratify":[327],"pulmonary":[329],"reserve,":[330],"separately,":[334],"analyze":[336],"competing":[343],"risks.":[344]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}